Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Investors Hangout MVP's Message Board

$HALB Halberd, Inc. (HALB) Reports Elimination of

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 99138
(Total Views: 150)
Posted On: 01/13/2022 2:50:53 PM
Avatar
Posted By: louied91
$HALB Halberd, Inc. (HALB) Reports Elimination of Target Antigens, Progressing to Treatments for Neurodegenerative Diseases


https://www.accesswire.com/683313/halberd-inc...e-diseases

JACKSON CENTER, PA / ACCESSWIRE / January 13, 2022 / Halberd, Inc. (OTC PINK:HALB) ("HALB" or the "Company" , an innovative biotech company focused on developing treatments for difficult-to-cure debilitating diseases, today announces that they have been able to successfully eliminate Beta Amyloid and Interleukin-4 (IL-4) from synthetic cerebral spinal fluid (CSF) in its latest in-vitro laboratory testing. The Company's latest testing accomplishments support its long-standing goal of successfully eradicating all of the top ten target antigens from a static sampling of CSF, thereby permitting control of these target antigens to the prescribed homeostasis level under physician care. Our progress is illustrated in the table below linked to neurodegenerative diseases which have remained virtually untreated over the centuries.

Dr. Mitchell S. Felder, HALB's Chief Technology Officer and a board-certified attending neurologist stated, "Beta-Amyloid is widely recognized to be a major factor of Alzheimer's Disease. Halberd's unique ability to eradicate Beta-Amyloid, coupled with its eradication of IL-4 and its previous elimination of TNF-Alpha, Phosphorylated-Tau, other target antigens, and inflammatory cytokines from CSF, leads the Company to believe it has achieved unparalleled progress toward slowing or preventing the onset of Alzheimer's Disease and other neurodegenerative diseases, such as Epilepsy, Lou Gehrig's Disease (ALS), PTSD, Traumatic Brain Injury, and Chronic Traumatic Encephalopathy. Although comparative, competitive data has been difficult to obtain, we believe that this is a truly spectacular result in comparison to any other competitive claimed therapies available anywhere in the world. The best we can determine from competition is that they claim to eliminate only 5-15% of Beta-Amyloid from CSF within a month of expensive treatment."

"Our successful in-vitro laboratory tests prove our technology can be used to regulate any of the top ten neurodegenerative linked targeted antigens to acceptable levels, as directed by attending physicians," stated William A. Hartman, HALB's Chairman, President, & CEO. "The significance of these continuing series of tests is that Halberd's three issued patents as well as its 20 related provisional patent applications prove that this unique technology belongs exclusively to Halberd Corporation."


(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us